Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Feb 2026, Mar 2026, Jun 2026, Jul 2026, Aug 2026 and Sep 2026.
- Largest single sale: $3.8M (40,985 shares) of Mirum Pharmaceuticals, Inc. on Mar 16, 2026. Filing
- Last sale before this period: Aug 11, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer, Director | Jul 17, 2019 | Oct 6, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 6, 2026, Mirum Pharmaceuticals, Inc.: 12,197 shares acquired by exercising options. 1 filing: 1
- Sep 1, 2026, Mirum Pharmaceuticals, Inc.: sold 30,000 shares for $3.0M, under a disclosed plan; 30,000 shares acquired by exercising options. 1 filing: 1
- Aug 10, 2026, Mirum Pharmaceuticals, Inc.: sold 20,000 shares for $2.0M, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
- Jul 6, 2026, Mirum Pharmaceuticals, Inc.: sold 20,000 shares for $2.4M, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
- Jun 1, 2026, Mirum Pharmaceuticals, Inc.: sold 30,000 shares for $2.9M, under a disclosed plan; 30,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.